Latobate 250 Tablet contains Lanthanum Carbonate 250 mg, a potent phosphate binder widely used in chronic kidney disease (CKD) patients with hyperphosphatemia.
This tablet works by binding dietary phosphate in the gastrointestinal tract, reducing serum phosphate levels and helping maintain optimal mineral and bone balance. It is ideal for CKD patients undergoing dialysis or those with elevated phosphate levels requiring consistent phosphate management.
Clinically, Latobate 250 Tablet is used to prevent complications of hyperphosphatemia, such as secondary hyperparathyroidism and vascular calcification, ensuring safe and effective renal management.
The tablet ensures accurate dosing, high patient compliance, and reliable therapeutic outcomes, making it suitable for hospitals, nephrology clinics, dialysis centers, and specialty pharmacies that demand high-quality phosphate binder therapy.
Common side effects may include nausea, vomiting, constipation, diarrhea, abdominal discomfort, or flatulence. Rarely, hypersensitivity reactions or severe gastrointestinal obstruction may occur.
Latobate 250 Tablet is indicated for the management of hyperphosphatemia in patients with chronic kidney disease, particularly those on dialysis. It helps control phosphate levels, reducing the risk of bone and cardiovascular complications associated with elevated serum phosphate.
Use Latobate 250 Tablet strictly under medical supervision. Take the tablet with meals as prescribed. Inform your doctor of any history of gastrointestinal disorders, bowel obstruction, or kidney issues. Contact your physician immediately if severe abdominal pain, persistent vomiting, or allergic reactions occur.
Store in a cool, dry place below 25°C. Protect from moisture and direct sunlight. Keep out of reach of children. Do not use beyond the expiry date.